Lastest News
Which are outstanding tetravalent vaccines even for the young?
As the new era of tetravalent influenza vaccines started after trivalent vaccines, the industry is paying attention to the rivalry between GSK’s Fluarix Tetra Prefilled Syringe and Sanofi-Pasteur’s Vaxigrip Tetra.
Th...
Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer
In order to extend treatment opportunities for life-threatening patients in emergency and patients with no other option for their treatment, the Ministry of Food and Drug Safety(MFDS) started the ‘Use Approval of Clin...
Who will be the next Pharmaceutical Safety Bureau Director?
As Pharmaceutical Safety Bureau Director Won-Shik Lee at the Ministry of Food and Drug Safety(MFDS), who was appointed by public participation on September 2016, resigned the position, the industry is paying attention...
Celltrion completes clinical trials for Remsima SC for European approval
Celltrion completed a Phase III clinical trial to get approval of ‘Remsima SC(CT-P13 SC),’ a subcutaneous injection version of the antibody biosimilar for the treatment of autoimmune therapy ‘Remsima(generic name: inf...
Sales listed pharmas made in the first half of the year
KOSPI listed pharmaceutical companies had a slightly higher sales increase rate than KOSDAQ listed pharmaceutical companies in the 1st half of the year.
Yakup Shinmoon(www.yakup.com) analyzed 38 KOSPI and 31 KOSDAQ l...
Rapidly changing ‘marketing method’ for pharmas
The original method of marketing is changing among pharmaceutical companies.
While medical representatives have used a method to visit hospitals in person, the method is changing to hold overnight symposiums(product ...
3 of 4 consumers do not know whether they are taking ‘original’ or ‘generic’
Bayer Korea conducted a survey about ‘patient recognition on medicines they are taking regularly’ on 1,000 people between the 40s and 60s through a Korean research company ‘Open Survey,’ and announced the survey resul...
"Poisonous clauses from Special Law for Regulation on Special Economic Zone have already been removed"
While the health care field is worrying more and more about the Restriction-Free Zone Act, the ruling party announced they removed poisonous clauses in the ‘Special Law for Regulation on Special Economic Zone.’
The M...
How well listed pharmas did with net profits?
Both KOSPI and KOSDAQ listed pharmaceutical companies experienced a decrease in the average net profits in the first half of this year, and KOSDAQ pharmas had a larger decrease. On the other hand, KOSDAQ pharmas had a...
Korea’s largest pharmaceutical convention ‘CPhI Korea’ has begun
The Korea’s largest 3-day pharmaceutical convention ‘CPhI Korea’ has begun
The Korea Pharmaceutical Traders Association will hold ‘CPhI Korea 2018’ jointly with a global convention company UBM Korea at Hall D, COEX o...
H&B and drug stores reaching about 1,700 stores in Korea
It has been 20 years since CJ(CheilJedang at the time) opened the first Olive Young store as a drug store in 1999. There are now about 1,700 H&B(Health & Beauty) and drug stores in Korea.
Currently, there are 1,173 O...
Korean Pharmaceutical Association being active top stop Restriction-Free Zone Act
Korean Pharmaceutical Association Chairman Chan-Hwi Cho visited the National Assembly on the 24 to take actions to stop the Service Industry Development Act and the Restriction-Free Zone Act that destroy the people’s ...
Daewoong Chairman Jae-Seung Yoon, “I’ll take a step out of the management for careless words and actions”
Daewoong Pharmaceutical Chairman Jae-Seung Yoon announced to step out of his position for the issue he created with his words and actions.
“For the YTN’s repot about my words and actions, I deeply apologize to everyo...
MOHW starts to select innovative pharmaceutical companies for the 4th time
The Ministry of Health and Welfare(Minister Neung-Hoo Park, MOHW) and the Korea Health Industry Development Institute announced on the 27th that they would take applications for ‘innovative pharmaceutical company’ bet...
How did listed pharmas with operating profits?
KOSDAQ listed pharmaceutical companies had a significantly higher operating profit rate on average than KOSPI listed pharmaceutical companies in the first half of this year.
Yakup Shinmoon(www.yakup.com) analyzed 38 ...
